Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Long-Term Outcomes of Patients with Isolated Sub-Segmental Pulmonary Embolism Managed without Anticoagulant Therapy

Cameron Brown, Marc Carrier, Ranjeeta Mallick, Amanda Pecarskie, Joseph R. Shaw, Gregoire Le Gal

Blood (2024) 144 (Supplement 1): 815.

https://doi.org/10.1182/blood-2024-210935

Published: 2024

Journal Articles

Performance Status, Cancer-Associated Thrombosis, and Bleeding: A Post-Hoc Analysis of the Avert Trial

Nicola Potere, Ranjeeta Mallick, Yan Xu, Tzu-Fei Wang, Philip Stephen Wells, Marc Carrier

Blood (2024) 144 (Supplement 1): 4018.

https://doi.org/10.1182/blood-2024-210101

Published: 2024

Journal Articles

Characterizing Diagnostic Investigations for Suspected Pulmonary Embolism in Postpartum Individuals

Sophie Greutert, Gurjeet Bhangu, Helia Robert-Ebadi, Jeffrey Kline, Marc Righini, Andrea Penaloza, Arnaud Perrier, Waleed Ghanima, Ranjeeta Mallick, Toshihiko Takada, Nick Van Es, Frederikus A Klok, Geert-Jan Geersing, Grégoire Le Gal, Leslie Skeith

Blood (2024) 144 (Supplement 1): 1249.

https://doi.org/10.1182/blood-2024-203216

Published: 2024

Journal Articles

Inherited Thrombophilia Gene Mutations and Risk of Venous Thromboembolism in Cancer: A Systematic Review and Meta-Analysis

Danielle Carole Roy, Tzu-Fei Wang, Ronda Lun, Amin Zharai, Ranjeeta Mallick, Dylan Burger, Gabriele Zitikyte, Steven Hawken, Philip Stephen Wells

Blood (2023) 142 (Supplement 1): 4017.

https://doi.org/10.1182/blood-2023-181941

Published: 2023

Journal Articles

Efficacy and Safety of Extended Duration Postoperative Thromboprophylaxis with Low-Molecular-Weight-Heparin Among Subgroups of Patients Undergoing Surgical Resection of Colorectal Cancer: A Post-Hoc Analysis of the Periop-01 Trial

Laura Girardi, Rebecca Auer, Ranjeeta Mallick, Tzu-Fei Wang, Marc Carrier

Blood (2023) 142 (Supplement 1): 2637.

https://doi.org/10.1182/blood-2023-179689

Published: 2023

Journal Articles

Blood Biomarkers and Risk of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis

Danielle Carole Roy, Tzu-Fei Wang, Ronda Lun, Amin Zharai, Ranjeeta Mallick, Dylan Burger, Gabriele Zitikyte, Steven Hawken, Philip Stephen Wells

Blood (2023) 142 (Supplement 1): 4018.

https://doi.org/10.1182/blood-2023-186880

Published: 2023

Journal Articles

CAR-T Therapy for the Treatment of Relapsed/Refractory CD19 Positive Large B Cell Lymphoma: Canadian Real-World Evidence

Xiu Xia Sherry Tan, Melissa Maltez, Ranjeeta Mallick, Linda Hamelin, Sheryl McDiarmid, Michael Kennah, Harold Atkins, Natasha K. Kekre

Blood (2023) 142 (Supplement 1): 6923.

https://doi.org/10.1182/blood-2023-179044

Published: 2023

Journal Articles

Thrombophilia Gene Mutations for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy

Danielle Carole Roy, Tzu-Fei Wang, Ranjeeta Mallick, Philip S. Wells, Marc Carrier, Steven Hawken

Blood (2022) 140 (Supplement 1): 2792–2793.

https://doi.org/10.1182/blood-2022-160158

Published: 2022

Journal Articles

Blood Biomarkers for the Prediction of Venous Thromboembolism in Perioperative or Hospitalized Cancer Patients: A Systematic Review

Danielle Carole Roy, Amin Zahrai, Ronda Lun, Tzu-Fei Wang, Steven Hawken, Ranjeeta Mallick, Dylan Burger, Philip S. Wells

Blood (2022) 140 (Supplement 1): 5700–5701.

https://doi.org/10.1182/blood-2022-159792

Published: 2022

Journal Articles

Efficacy and Safety of Apixaban for Primary Prevention of Thromboembolism in Cancer Patients with a Newly Inserted Central Venous Catheter: A Post-Hoc Analysis of the Avert Trial

Willem Brandt, Cameron Brown, Amin Zahrai, Ranjeeta Mallick, Philip S. Wells, Marc Carrier

Blood (2021) 138 (Supplement 1): 2133.

https://doi.org/10.1182/blood-2021-148683

Published: 2021

Journal Articles

Safety and Efficacy of Apixaban Thromboprophylaxis in Ambulatory Cancer Patients By Renal Function: A Subgroup Analysis of the Avert Trial

Tzu-Fei Wang, Ranjeeta Mallick, Marc Carrier, Philip S. Wells

Blood (2021) 138 (Supplement 1): 3229.

https://doi.org/10.1182/blood-2021-149681

Published: 2021

Journal Articles

Enhanced VTE Risk Stratification in Ambulatory Patients with Cancer

Joseph R. Shaw, MD, Ranjeeta Mallick, PhD MSc, BSc, Marc Carrier, MD, Anton Ilich, MD, Nigel S. Key, MBChB, FRCP, Philip S. Wells, MDMSc,FRCP

Blood (2019) 134 (Supplement_1): 634.

https://doi.org/10.1182/blood-2019-126306

Published: 2019

Journal Articles

Safety and Efficacy of Apixaban Thromboprophylaxis in Cancer Patients with Metastatic Disease: A Subgroup Analysis of the Avert Trial

William Knoll, BSc, Ranjeeta Mallick, PhD MSc, BSc, Philip S. Wells, MDMSc,FRCP, Marc Carrier, MD

Blood (2019) 134 (Supplement_1): 1140.

https://doi.org/10.1182/blood-2019-128834

Published: 2019

Journal Articles

Thromboprophylaxis for Patients with Newly Diagnosed Vs. Recurrent Cancers: A Post-Hoc Analysis of the Avert Trial

Marina Atalla, James Zhang, MD, Ranjeeta Mallick, PhD MSc, BSc, Philip S. Wells, MDMSc,FRCP, Marc Carrier, MD

Blood (2019) 134 (Supplement_1): 3660.

https://doi.org/10.1182/blood-2019-122970

Published: 2019

Journal Articles

Intermediate Vs High Dose Busulfan-Based Conditioning for Allogeneic Cell Transplantation in Patients with Acute Leukemia or Myelodysplastic Syndromes from HLA Matched Related or Unrelated Donors: Achieving the Same with Less

Mohamad Sobh, PharmD, Lothar B. Huebsch, MD, Mitchell Sabloff, MSc,MDFRCPC, Jill Fulcher, MDPhDMRCPI FRCPath(UK), Sultan Altouri, MDFRCPC, Michael Kennah, MD, Elizabeth Drouin, MD, David S. Allan, MD FRCPC, MSc, Harold Atkins, MD, Grace Christou, MD, Pierre Villeneuve, MD PhD, Alexandre P.Blanchard, PhD, Kelsey Maclellan, Ranjeeta Mallick, PhD MSc, BSc, Nicole B. Laferriere, MD PhD, Sathish Gopalakrishnan, MD, Sita D. Bhella, MD, Natasha Kekre, MDFRCPC, Christopher Bredeson, MDFRCPC,MSc

Blood (2019) 134 (Supplement_1): 3263.

https://doi.org/10.1182/blood-2019-122436

Published: 2019

Journal Articles

Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant

Adam Bryant, MD, Ranjeeta Mallick, Lothar B. Huebsch, MD, David S. Allan, MD FRCPC, Harold Atkins, MDFRCPC, Grizel Anstee, MD, Isabelle Bence-Bruckler, MD FRCPC, Linda Hamelin, Michael Hodgins, MD, Mitchell Sabloff, MDM, Nicholas Scrivens, Dawn C. Maze, MDFRCPC,MSc, Christopher N. Bredeson, MD MSc, FRCPC, Natasha Kekre, MDMPH, FRCPC

Blood (2016) 128 (22): 5782.

https://doi.org/10.1182/blood.V128.22.5782.5782

Published: 2016

Journal Articles

Factors Influencing Long-Term Hematopoietic Function Following Autologous Stem Cell Transplantation

Alissa Visram, MD, Natasha Kekre, MD MPH, FRCPC, Christopher N. Bredeson, MD MSc, FRCPC, Jason Tay, MDFRCPC MSc, Lothar B. Huebsch, MD, Sheryl McDiarmid, Ranjeeta Mallick, PhD, Mitchell Sabloff, MDM, Harold Atkins, MDFRCPC, David S. Allan, MD FRCPC, Alan Tinmouth, MD FRCPC, Linda Hamelin, Lisa Martin, Dawn Maze, MD FRCPC MSc

Blood (2016) 128 (22): 2186.

https://doi.org/10.1182/blood.V128.22.2186.2186

Published: 2016

Journal Articles

A Comparison of Cyclophosphamide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Amarilis Figueiredo, MD, Harold Atkins, MD FRCPC, Ranjeeta Mallick, PhD, Natasha Kekre, MD MPH, FRCPC, Andrea Kew, MD, Arleigh McCurdy, MD

Blood (2016) 128 (22): 4519.

https://doi.org/10.1182/blood.V128.22.4519.4519

Published: 2016

Journal Articles

Low Molecular Weight Heparin for Prevention of Placenta-Mediated Pregnancy Complications: An Individual Patient Data Meta-Analysis

Blood (2015) 126 (23): 890.

https://doi.org/10.1182/blood.V126.23.890.890

Published: 2015

Journal Articles

The Influence of the Duration of Storage of Red Blood Cells On Cancer Survival

Natasha Kekre, MD, FRCPC, Ranjeeta Mallick, David S. Allan, MD, MSc, Alan Tinmouth, MD, FRCPC, Jason Tay, MD, MSc, FRCPC

Blood (2012) 120 (21): 1184.

https://doi.org/10.1182/blood.V120.21.1184.1184

Published: 2012

NARROW

Long-Term Outcomes of Patients with Isolated Sub-Segmental Pulmonary Embolism Managed without Anticoagulant Therapy

Performance Status, Cancer-Associated Thrombosis, and Bleeding: A Post-Hoc Analysis of the Avert Trial

Characterizing Diagnostic Investigations for Suspected Pulmonary Embolism in Postpartum Individuals

Inherited Thrombophilia Gene Mutations and Risk of Venous Thromboembolism in Cancer: A Systematic Review and Meta-Analysis

Efficacy and Safety of Extended Duration Postoperative Thromboprophylaxis with Low-Molecular-Weight-Heparin Among Subgroups of Patients Undergoing Surgical Resection of Colorectal Cancer: A Post-Hoc Analysis of the Periop-01 Trial

Blood Biomarkers and Risk of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis

CAR-T Therapy for the Treatment of Relapsed/Refractory CD19 Positive Large B Cell Lymphoma: Canadian Real-World Evidence

Thrombophilia Gene Mutations for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy

Blood Biomarkers for the Prediction of Venous Thromboembolism in Perioperative or Hospitalized Cancer Patients: A Systematic Review

Efficacy and Safety of Apixaban for Primary Prevention of Thromboembolism in Cancer Patients with a Newly Inserted Central Venous Catheter: A Post-Hoc Analysis of the Avert Trial

Safety and Efficacy of Apixaban Thromboprophylaxis in Ambulatory Cancer Patients By Renal Function: A Subgroup Analysis of the Avert Trial

Enhanced VTE Risk Stratification in Ambulatory Patients with Cancer

Safety and Efficacy of Apixaban Thromboprophylaxis in Cancer Patients with Metastatic Disease: A Subgroup Analysis of the Avert Trial

Thromboprophylaxis for Patients with Newly Diagnosed Vs. Recurrent Cancers: A Post-Hoc Analysis of the Avert Trial

Intermediate Vs High Dose Busulfan-Based Conditioning for Allogeneic Cell Transplantation in Patients with Acute Leukemia or Myelodysplastic Syndromes from HLA Matched Related or Unrelated Donors: Achieving the Same with Less

Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant

Factors Influencing Long-Term Hematopoietic Function Following Autologous Stem Cell Transplantation

A Comparison of Cyclophosphamide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Low Molecular Weight Heparin for Prevention of Placenta-Mediated Pregnancy Complications: An Individual Patient Data Meta-Analysis

The Influence of the Duration of Storage of Red Blood Cells On Cancer Survival

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only